TickerKhojHospitals & Diagnostics · Hospital/Nursing Management · NSE: KMCSHIL · data 2026-11-03
KMC Speciality Hospitals (India) Limited
In plain words
Price: 22.0% below its 52-week high of ₹185.5.
Delivery: 35.4% of traded shares were kept for delivery over the last 10 sessions, against 40.4% over the last 53.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹331 cr |
| Net profit (last 12 months) | ₹56 cr |
| Sales growth, 3 years (yearly) | 25.2% |
| Profit growth, 3 years (yearly) | 20.5% |
At a glance
P/E 42.3, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 24.9%, ROCE 25.1%, operating margin 23.4%: how much profit it earns on the money it uses.
Debt/equity 0.40, Profit growth 20.5% and sales growth 25.2% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (24.9%).
- Healthy operating margin (23.4%).
- Profit grew 20.5% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
15/100 · Weak over the last ~60 sessions, data 2026-11-02
- Delivery vs usual 10/30: Delivery 28.7% over the last 20 sessions vs 16.4% in the 40 before (1.75x); shares delivered per day 0.95x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is KMC Speciality Hospitals (India) Limited debt-free?
Its latest reported debt-to-equity ratio is 0.4.
What is KMC Speciality Hospitals (India) Limited's P/E ratio?
About 42.3, based on the last 12 months' earnings and a price of ₹144.74 (data 2026-11-03).
What is the 52-week high and low of KMC Speciality Hospitals (India) Limited?
The 52-week high is ₹185.5 and the 52-week low is ₹128.48.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| KMC Speciality Hospitals (India) Limited | ₹144.74 | ₹2,422 cr | 42.3 | — | 24.9% | 25.1% | 0.4 | +5.1% |
| Artemis Medicare Services Ltd. | ₹283.6 | ₹4,626 cr | 38.5 | — | 11.7% | 12% | 0.28 | +11.7% |
| Indraprastha Medical Corporation Limited | ₹310.65 | ₹2,797 cr | 15.2 | — | 27.5% | 30% | 0.05 | -48.0% |
| Shalby Ltd. | ₹120.41 | ₹1,306 cr | 32.7 | — | 3.7% | 6% | 0.59 | -50.2% |
| Gujarat Kidney & Super Speciality Ltd. | ₹163.59 | ₹1,289 cr | 81.5 | — | 11.1% | 14.7% | 0.12 | +36.3% |
| GPT Healthcare Limited | ₹134.8 | ₹1,089 cr | 23.4 | — | 16.3% | 16.2% | 0.34 | -10.3% |
Compare KMCSHIL with ARTEMISMED in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open KMCSHIL in TickerKhoj →